Back to News
Market Impact: 0.5

Exxon Mobil: The Cure For Low Prices Is Low Prices

XOM
Energy Markets & PricesCommodities & Raw MaterialsCompany FundamentalsAnalyst InsightsInvestor Sentiment & Positioning
Exxon Mobil: The Cure For Low Prices Is Low Prices

An analyst at Seeking Alpha suggests Exxon Mobil (XOM) presents a contrarian buying opportunity due to low oil prices failing to incentivize new drilling, positioning the company to capitalize on the next upcycle with low-cost projects like those in Guyana. The analyst believes the market undervalues Exxon's cost improvements and advantaged assets, anticipating higher average profitability in the next business cycle. The analyst discloses a long position in XOM.

Analysis

The presented material advocates a contrarian investment thesis for Exxon Mobil (XOM), positing that current market pessimism towards oil and gas stocks, driven by concerns of oversupply, creates a buying opportunity. This view is predicated on the argument that existing low oil prices are insufficient to incentivize new drilling, which historically leads to recovery cycles. Exxon Mobil is specifically highlighted for its strategic positioning to capitalize on an anticipated upcycle through its commitment to low-cost, high-profitability projects, with its Guyana operations cited as a key example. The analysis suggests that the market currently undervalues Exxon's significant cost improvements and the growth of its advantaged asset base, leading to an expectation that the company will achieve higher average profitability in the next business cycle compared to the last. The analyst, who discloses a beneficial long position in XOM, indicates this perspective is rooted in the cyclical nature of the oil and gas industry, requiring patience and experience to navigate. The sentiment signals corroborate this bullish outlook, with a strongly positive sentiment score of 0.8 for both the general article and specifically for XOM.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo